Skip to content

Effectiveness of Magnetic Stimulation of Brain In Treatment of functional neurological symptom disorder (seizure type)

Assessment and comparison of short term efficacy of adjunctive continuous theta burst stimulation over supplementary motor area in functional neurological symptom disorder (seizure type): a randomized sham-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050710
Enrollment
40
Registered
2023-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F445- Conversion disorder with seizuresor convulsions

Interventions

Intervention1: Continuous theta burst stimulation: cTBS will be delivered over SMA for 2 sessions daily for any 5 days of a week for 1 week Control Intervention1: Placebo: placebo treatment will be

Sponsors

Sri Guru Ram Rai Institute Of Medical And Health Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with a diagnosis of FND-S, based on the diagnostic criteria of diagnostic and statistical manual of mental disorder, fifth edition (DSM 5) or international classification of disease (ICD 11) and confirmed by video EEG monitoring or video monitoring. 2.Patient aged between 15-59 years. 3.Patient with diagnosis of PNES with monthly frequency of >3 seizures (for at least a month). 4.Patient giving written consent to participate in protocol. For an adolescent, sample consent will be taken from the guardian. 5.Normotensive patients. 6.Patients not receiving any psychotherapy in last one month.

Exclusion criteria

Exclusion criteria: 1.Patient is uncooperative for the procedure. 2.Patient with history of previous or current epilepsy 3.Patients receiving ECT in past 6 months. 4.Patient with severe mental disorders (SMD). 5.Patient with implanted metallic devices. 6.Any co morbid substance use disorders except nicotine and caffeine (as per DSM 5). 7. Patient with other neurovascular comorbidities (tumor,cerebrovascular events (CVE), cranio-encephalic trauma. 8.Significant unstable medical condition like uncontrolled hypertension, complicated diabetes mellitus or any organ failure.

Design outcomes

Primary

MeasureTime frame
frequency of dissociative symptoms - PNES SCORE,DESTimepoint: PNES SCORE , DES will be applied at baseline, 7th day and 21st day

Secondary

MeasureTime frame
To compare the quantitative change in depressive and anxiety symptoms in patients suffering from functional neurological symptom disorder, seizure type following active continuous theta burst stimulation compared with sham stimulation. To study the correlation among changes if any in dissociative, socio-demographic variables, depression, anxiety scores and other clinical measures following active continuous theta burst stimulation in patients suffering from functional neurological symptom disorder, seizure typeTimepoint: HADS, CGI, WHO-QOL BREF will be applied at baseline, 7th day and 21st day

Countries

India

Contacts

Public ContactDr Ayushi Gera

Sri Guru Ram Rai Institute of Medical and Health Sciences

shobit.garg@gmail.com8958534261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026